Detection of 2-Pentylfuran in the breath of patients with Aspergillus fumigatus

Medical Mycology

Volumn 47, Issue 5, 2009, Pages 468-476

  Chambers, Stephen T ^a,b   Syhre, Mona ^a   Murdoch, David R ^a,c   McCartin, Fiona ^a   Epton, Michael J ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

2 pentylfuran; Aspergillus fumigatus; Breath test; Mass spectroscopy

Indexed keywords

2 PENTYLFURAN; BIOCHEMICAL MARKER; FURAN DERIVATIVE; ITRACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BREATH ANALYSIS; BRONCHIECTASIS; CHEMICAL STRUCTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FUNGAL COLONIZATION; FUNGAL METABOLISM; FUNGUS CULTURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; MASS FRAGMENTOGRAPHY; NEUTROPENIA; NONHUMAN; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ASPERGILLUS FUMIGATUS; BACTERIA; BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CARRIER STATE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; FOOD; FURANS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; PULMONARY ASPERGILLOSIS; SENSITIVITY AND SPECIFICITY; SPUTUM;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; MAMMALIA;

EID: 70449649738     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802475212     Document Type: Article

References (29)

1. Herbrecht R, Denning DW, Patterson TF, et al. and the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415. (Pubitemid 34851833)
2. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366.
3. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335-347.
4. Verweij PE, Rijs AJ, De Pauw BE, et al. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995; 48: 474-476.
5. Costa C, Costa JM, Desterke C, et al. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 2002; 40: 2224-2227.
6. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med 1992; 86: 243-248.
7. Scotter JM, Campbell P, Anderson TP, et al. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis. Pathology 2005; 37: 246-253.
8. Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223-3228.
9. Syhre M, Scotter JM, Chambers ST. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol 2008; 46: 209-215.
10. Chamilos G, Kontoyiannis DP. Defining the diagnosis of invasive aspergillosis. Med Mycol 2006: 44(Suppl. 1):163-172.
11. Gao P, Korley F, Martin J, Chen BT. Determination of unique microbial volatile organic compounds produced by five Aspergillus species commonly found in problem buildings. AIHA J 2002; 63: 135-140.
12. Phillips M, Herrera J, Krishnan S, et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B: Biomed Sci Appl 1999; 729: 75-88. (Pubitemid 29264111)
13. Nebesny E, Budryn G, Kula J, Majda T. The effect of roasting method on headspace composition of robusta coffee bean aroma. Euro Food Res Technol 2006; 225: 9-19.
14. Tressl R, Bahri D, Holaer M, Kossa T. Formation of flavour components in asparagus. 2. J Agri Food Chem 1977b; 25: 459-463.
15. Wongpornchai S, Dumri K, Jongkaewwattana S, Siri B. Effects of drying methods and storage time on the aroma and milling quality of rice (Oryza sativa L.) Food Chem 2004; 87: 407-414.
16. Magan N, Evans P. Volatiles as an indicator of fungal activity and differentiation between species, and the potential use of electronic nose technology for early detection of grain spoilage. J Stored Prod Res 2000; 36: 319-340.
17. Schnurer J, Olsson J, Borjesson T. Fungal volatiles as indicators of food and feeds spoilage. Fungal Genet Biol 1999; 27: 209-217.
18. De Oliveira E, Giavina-Bianchi P, Fonseca LA, Franca AT, Kalil J. Allergic bronchopulmonary aspergillosis diagnosis remains a challenge. Respir Med 2007; 101: 2352-2357.
19. Ascioglu S, Rex JH, de Pauw B, et al. and Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
20. Isenburg HD. Clinical Microbiology Procedure Handbook, 2nd edn. Washington, DC: ASM Press, 2004.
21. Sharpe SE. Cumitech 7B, Lower Respiratory Tract Infections. Washington, DC: ASM Press, 2004.
22. Larone DH. Medically Important Fungi. A Guide to Identification, 4th edn. Washington, DC: ASM Press, 2002.
23. Perfect JR, Cox GM, Lee JY, et al. and Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospitalbased survey of aspergillosis. Clin Infect Dis 2001; 33: 1824-1833.
24. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986; 81: 249-254.
25. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am JMed 1996; 100: 171-178.
26. Lutteke T, Kreig P, Furstenberger G, von der Lieth C-W. L. LOXDB - a database on lipoxygenases. Bioinformatics 2003; 19: 2482-2483.
27. Spiteller D, Spiteller G. Identification of toxic 2,4-decadienal in oxidized, low-density lipoprotein by solid phase microextraction. Angew Chem Int Ed Engl 2000; 39: 583-584.
28. Dudda A, Spiteller G, Kobelt F. Lipid oxidation products in ischaemic porcine heart tissue. Chem Physics Lipid 1996; 82: 39-51.
29. Liavonchanka I, Feussner I. Lipoxygenases: Occurrence, functions and catalysis. J Plant Physiol 2006; 163: 348-357.